Early Cancer Detection Test
Early Cancer Detection Test
Here at Dynamic, we're proud to announce our first early cancer detection test! This test, also known as EPISEEK, is a liquid biopsy test and is able to detect circulating tumor DNA from more than 20 common cancer types as a part of a comprehensive ancology workup!
Which cancers can EPISEEK detect?
- Lung
- Breast
- Prostate
- Colorectal
- Pancreatic
- Head and Neck
- Urinary Bladder
- Esophageal
*The EPISEEK liquid biopsy test is intended to be used as a complimentary tool to established cancer screening assessments
So what is EPISEEK and how does it work?
The Precision Epigenomics Liquid Biopsy Test, EPISEEK, is a blood-based test designed to detect circulating tumor DNA (ctDNA) from a simple blood draw. EPISEEK analyzes epigenomic modifications present on the ctDNA. Special software is used to analyze the results and aids the pathologist to issue a report that specifies if an abnormal signal is detected or if no cancer signal is detected.
*PLEASE NOTE
This sample must be recieved by our lab within 48 hours of collection.